Safety and Efficacy of Oxymetazoline HCl Cream 1.0% in Patients With Persistent Erythema Associated With Rosacea
Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and efficacy of oxymetazoline hydrochloride (HCl) cream
1.0% (AGN-199201) once daily compared to vehicle for the treatment of persistent moderate to
severe facial erythema associated with rosacea.